Bio-Techne (TECH) Net Cash Flow Growth (1y) (2010 - 2026)
Powered by 
Analysis
Bio-Techne (TECH) Net Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | 172.72% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 53.21% |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | 47.11% |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 75.60% |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | -100.75% |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 149.49% |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | -104.22% |
| 10 | Bio-Techne | 11.29 Bn | 11.03 Bn | 211.39 Mn | 576.28% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 576.28% |
| Mar 31, 2026 | 206.51% |
| Dec 31, 2025 | 708.09% |
| Sep 30, 2025 | -152.28% |
| Jun 30, 2025 | 23.69% |
| Mar 31, 2025 | -395.14% |
| Dec 31, 2024 | 79.40% |
| Sep 30, 2024 | 231.96% |
| Jun 30, 2024 | -87.88% |
| Mar 31, 2024 | 130.53% |
| Dec 31, 2023 | -177.20% |
| Sep 30, 2023 | -606.10% |
| Jun 30, 2023 | 195.43% |
| Mar 31, 2023 | 15.36% |
| Dec 31, 2022 | -163.62% |
| Sep 30, 2022 | 181.41% |
| Jun 30, 2022 | 43.84% |
| Mar 31, 2022 | -337.40% |
| Dec 31, 2021 | 232.24% |
| Sep 30, 2021 | -92.89% |